Related by context. All words. (Click for frequent words.) 78 MyVax R 78 personalized immunotherapy 74 Personalized Immunotherapy 72 Insegia 71 Aviptadil 70 Initiate Clinical Trial 70 VitiGam 69 TLK# 69 Altastaph 69 THR beta agonist 69 acetonide FA 68 oral prodrug 68 ALN PCS 68 lucinactant 68 Surfaxin LS 68 DPX Survivac 68 reslizumab 68 MAGE A3 ASCI 68 UPLYSO 68 TYZEKA 68 treat chronic sinusitis 68 CINTREDEKIN BESUDOTOX 68 Factor VIIa 68 EGRIFTA TM 67 KIACTA ™ 67 Onconase 67 investigational monoclonal antibody 67 BrachySil TM 67 targeted radiotherapeutic 67 CTAP# Capsules 67 Pegloticase 67 CMV vaccine 67 molecular imaging radiopharmaceutical 67 forodesine 67 DCVax R 67 successfully commercialize Iluvien 67 systemic immunosuppressive drugs 67 TKM ApoB 67 IMA# 67 L BLP# 67 Nektar proprietary 67 aerosolized KL4 surfactant 67 Mepact 67 Zemiva TM 67 G#DT 67 Initiates Enrollment 67 otelixizumab 67 drug ISA# 67 relapsed leukemia 67 FOLOTYN ® 67 Civacir 67 Zenapax 66 CYT# potent vascular disrupting 66 alvespimycin 66 liposomal ciprofloxacin 66 immunodeficiency disorders 66 MyVax 66 immunotherapeutic vaccine 66 faropenem 66 hypereosinophilic syndrome 66 novel immunotherapies 66 oncolytic virus therapies 66 refractory chronic lymphocytic 66 thalidomide Thalomid 66 isoform selective 66 SinuNase TM 66 therapeutic monoclonal antibody 66 CCR5 mAb 66 lumiliximab 66 Panzem R 66 GRNVAC1 66 IV Busulfex 66 dasatinib Sprycel 66 vidofludimus 66 VitiGam TM 66 Phase IIb clinical trials 66 NV1FGF 66 novel therapeutic antibodies 66 cystinosis patients 66 Virulizin ® 66 antibody MAb 66 IAP inhibitor 66 Pseudomonas aeruginosa infections 66 hyperphenylalaninemia HPA due 66 OvaRex 66 XL# XL# 66 Cx# [002] 66 lapatinib Tykerb 66 thetreatment 66 Cimzia TM 66 ELACYT 66 HepaGam B 66 PNT# 66 kidney urologic 66 Aflibercept 66 tiapamil 66 oral ridaforolimus 65 Phase #b/#a clinical 65 adult mesenchymal stem 65 Lixivaptan 65 Martin Nicklasson CEO 65 IAP inhibitors 65 Intravenous CP 65 CCR9 antagonist 65 Zingo TM 65 Aerosurf 65 lomitapide 65 Ceflatonin 65 Azedra 65 HuMax TAC 65 LEP ETU 65 TRO# 65 NeuVax 65 LymphoStat B TM 65 pediatric acute lymphoblastic 65 Xanafide 65 immuno inflammatory diseases 65 delivers fluocinolone acetonide FA 65 oral picoplatin 65 Interferon beta 65 Panzem R NCD 65 XmAb 65 OHR/AVR# 65 CRMD# 65 EP #R 65 Dacogen decitabine 65 JAK2 inhibitor 65 PANVAC VF 65 commercialize deforolimus 65 Alferon N 65 monoclonal antibody therapeutics 65 theranostic 65 IoGen 65 Onco TCS 65 Xyfid TM 65 Ception Therapeutics 65 HuLuc# 65 Potelligent Technology 65 HQK 65 ospemifene 65 Generx TM 65 EVIZON TM 65 Immunotherapeutic 65 malignant ascites 65 intranasal formulation 65 acadesine 65 Chimigen TM 65 FVIIa 65 TRISENOX ® 65 faropenem medoxomil 65 velafermin 65 OvaRex R 65 anti infective treatments 65 refractory gout 65 Troxatyl 65 cellular immunotherapy 65 IRX 2 65 PNP inhibitor 65 candidate deforolimus 65 hormone LHRH antagonist 65 either acutely decompensated 65 CA9 SCAN 65 incyclinide 65 SNT-MC#/idebenone 65 omega interferon 65 ATG Fresenius S 65 pharmacological chaperone 65 Initiates Clinical 65 myelodysplastic myeloproliferative diseases 65 polycythemia vera essential thrombocythemia 65 Specifid 64 LymphoStat B belimumab 64 Copegus ribavirin 64 generation purine nucleoside 64 SNS# T 64 cutaneous T 64 volociximab 64 Sudhir Agrawal D.Phil 64 PrevOnco 64 ONCONASE R 64 aerosolized AAT 64 XP# XP# 64 nonhuman primate model 64 HCD# [002] 64 sodium thiosulfate STS 64 docetaxel Taxotere ® 64 cMET 64 trastuzumab DM1 T DM1 64 Fodosine 64 SEPET TM 64 atacicept 64 subcutaneous formulation 64 Bezielle 64 Allovectin 7 R 64 ZFP Therapeutics 64 Begins Dosing 64 MKC# MT 64 hoFH 64 MAXY VII 64 BEXXAR 64 KNS # 64 Solazed 64 catheter occlusion 64 Iluvien TM 64 haematological cancers 64 Viramidine 64 BrachySil ™ 64 ALN TTR 64 romazarit 64 Allovectin 7 64 forodesine hydrochloride 64 diarrhea predominant irritable 64 elotuzumab 64 refractory angina 64 Pyridorin 64 ARIKACE ™ 64 Myocet 64 ATL# [002] 64 TOCOSOL Camptothecin 64 rolapitant 64 JAK#/JAK# inhibitor CYT# 64 Cloretazine 64 Sebivo 64 including eniluracil ADH 64 Noxafil 64 personalized dendritic 64 GVAX ® 64 Bioaccelerate compounds under 64 Egrifta 64 Omigard 64 busulfan 64 Archexin 64 ATIR 64 Manja Bouman CEO 64 KL4 surfactant 64 IL# PE#QQR 64 polysaccharide polymer 64 Solazed TM 64 synthetic retinoid 64 Saforis 64 Canvaxin TM 64 Vidaza azacitidine 64 MOVIPREP R 64 Hepatitis C Virus HCV 64 Evoltra ® 64 Peginterferon alfa 2b 64 RhuDex ® 64 Davanat 64 Onalta ™ 64 Hepatocellular Carcinoma HCC 64 HyACT 64 Achieves Primary Endpoint 64 RNAi therapeutic targeting 64 Tarvacin TM 64 HDL Selective Delipidation 64 pentostatin 64 BENLYSTA ® 64 Daclizumab 64 OncoVEX 64 Luveris 64 oral talactoferrin 64 novel antiviral therapeutics 64 Zenvia ™ 64 terlipressin 64 efaproxiral 64 PHX# 64 investigational therapies 64 SinuNase ™ 64 neuroendocrine cancers 64 Aggrastat ® tirofiban hydrochloride 64 Motavizumab 64 Elisabeth Lindner CEO 64 SomatoKine 64 Onalta 64 Hervé Hoppenot President 64 Syncria R 64 Familial Adenomatous Polyposis FAP 64 Cancidas 64 teplizumab 64 etanercept Enbrel 64 intranasal delivery 64 SUTENT ® 64 eTag assays 64 apricitabine ATC 64 PRT# 64 Azacitidine 64 omacetaxine mepesuccinate 64 vaginal candidiasis 64 MGd 64 Phase 2a clinical trials 64 R sorafenib tablets 64 Acute Radiation Syndrome ARS 64 BiovaxID TM 64 Annamycin 64 drug GAP #B# 64 acyclovir Lauriad R 64 liposomal formulation 64 oxypurinol 64 Xcytrin R 64 personalized cellular immunotherapy 64 JAK inhibitor 64 Proellex TM 64 Amgen Neulasta ® 64 OMNARIS HFA 64 multiple myeloma MM 64 chronic eosinophilic leukemia 64 ruxolitinib 64 GRN# 64 bardoxolone 64 INS# [001] 64 MYLOTARG 64 Fibrillex TM 64 MYDICAR 64 non nucleoside 64 im peramivir 64 Cleviprex TM clevidipine 63 Prodarsan R 63 DXL# 63 dasatinib Sprycel ® 63 AQ4N 63 immunosuppressant therapies 63 RIGScan CR 63 Poly ICLC 63 Bicifadine 63 coagulation disorders 63 Cintredekin Besudotox 63 systemically administered 63 intranasal insulin product 63 ClearPath HDR 63 Vivecon 63 talactoferrin 63 Fx #A 63 Canvaxin 63 maribavir 63 IGF 1R inhibitor 63 Behcet uveitis 63 efficacious treatments 63 Cellegesic 63 histamine dihydrochloride 63 hepatocellular carcinoma liver 63 GA GCB 63 Syntonix 63 BHT DNA 63 Thiovir 63 chronic granulomatous disease 63 Kamada AAT 63 esophageal candidiasis 63 StaphVAX R 63 hyaluronidase enzyme 63 atypical hemolytic uremic syndrome 63 selective modulator 63 Soliris TM eculizumab 63 tafamidis 63 ReN# 63 Alinia 63 humanized antibody 63 Liprotamase 63 Pancreate 63 QuadraSphere 63 JAK1 63 relapsing remitting MS RRMS 63 SILENOR 63 predictive biomarkers 63 Hedgehog inhibitor 63 severe hypercholesterolemia 63 DermaVir Patch 63 Neogenix 63 IMC #B 63 human IgG1 monoclonal 63 inhaled liposomal ciprofloxacin 63 ADVEXIN p# therapy 63 CytoFab 63 Camvia 63 GW# [003] 63 IgG1 monoclonal antibody 63 metastatic malignant 63 SPRYCEL ® 63 Initiates Phase II 63 EOquin TM 63 Bioral Amphotericin B 63 therapeutic regimens 63 Marqibo TM 63 alpha1 antitrypsin deficiency 63 MAXY G# 63 Eculizumab 63 tubulin inhibitor 63 EVIZON TM squalamine lactate 63 Campath alemtuzumab 63 immunotherapeutic approaches 63 Urocidin TM 63 vinorelbine tartrate 63 chemotherapy induced neutropenia 63 Genentech Rituxan 63 TKM PLK1 63 OvaRex ® MAb 63 systemic RNAi therapeutic 63 Trofex 63 nephropathic cystinosis 63 NP2 Enkephalin 63 Evoltra TM 63 Neo Kidney Augment 63 proliferative disorders 63 subcutaneous immunoglobulin 63 docetaxel Taxotere R 63 targeting PCSK9 63 soluble tumor necrosis 63 Tectin TM 63 TELINTRA 63 MVA BN 63 targeted antifolate 63 photodisinfection 63 relapsed multiple myeloma 63 PDX pralatrexate 63 selective immunoproteasome inhibitor 63 postoperative ileus 63 Successfully Completes Phase 63 LEUKINE 63 inhaled AAT 63 immunosuppressive therapies 63 gastrointestinal mucositis 63 NurOwn 63 previously untreated follicular 63 Unit Dose Budesonide 63 Onalta TM 63 constipation OIC 63 TBC# 63 adalimumab Humira 63 p# inhibitor 63 mertansine 63 Panzem 63 lenalidomide Revlimid R 63 Prestara 63 ALK inhibitors 63 ATPace TM 63 Bioral 63 RNAi therapeutic targeting PCSK9 63 DCVax ® Brain 63 POSIDUR TM 63 Octreolin 63 AdhTAP 63 riociguat 63 Actimmune ® 63 Azedra TM 63 corticosteroid dexamethasone 63 Corgentin 63 Maxy G# 63 thiazolides 63 chronic thromboembolic pulmonary 63 tezampanel NGX# 63 CD# CEA 63 ONCASPAR 63 Gleevec resistant 63 markets HP Acthar 63 BCG refractory 63 Aganocide 63 Gamunex C 63 R#/MEM # 63 Inc. Nasdaq NLTX 63 Amplimexon 63 NEUMUNE 63 HCV polymerase 63 sd rxRNA 63 imatinib resistance 63 Monoclonal antibody 63 Reports Preclinical Data 63 TPI ASM8 63 nucleotide analog 63 sapropterin dihydrochloride Tablets 63 Rhucin ® recombinant 63 StemEx R 63 Initiates Phase 2b 63 Phenoptin 63 GED aPC 63 INTEGRILIN ® 63 pouchitis 63 HCV protease inhibitors 63 GLASSIA 63 immuno therapeutic 63 coagulation abnormalities 63 HepeX B 63 Omacetaxine 63 cilengitide 63 OncoVEX GM CSF 63 NovaBay Aganocide compounds 63 rALLy clinical trial 63 GnRH antagonists 63 essential thrombocythemia ET 63 ISTODAX 63 investigational humanized monoclonal antibody 63 oral RSD# 63 Smac mimetics 63 Kepivance 63 ADP receptor antagonist 63 rxRNA 63 dexanabinol 63 Prednisporin TM 63 dutogliptin 63 Stanate R 63 ONTAK 63 oxymorphone ER 63 molecular chaperone regulation 63 cinacalcet HCl 62 CIMZIA TM 62 radiation sensitizer 62 Symadex 62 cintredekin besudotox 62 GVAX cancer 62 Spiegelmer ® 62 obatoclax 62 uricase 62 inhalation powder 62 immunological diseases 62 E2F Decoy 62 FavId 62 Kuvan R 62 NeuroSTAT ® 62 QVAR 62 blood clot dissolver 62 anti CD3 monoclonal 62 Vidaza R 62 nosocomial pneumonia 62 StromaCel Inc. 62 prophylactic therapy 62 octreotide implant 62 lintuzumab SGN 62 ZOLINZA 62 ALV# 62 Friedreich Ataxia FRDA 62 SinuNase 62 Nipent R 62 small molecule activators 62 SANVAR 62 vaginally administered lidocaine 62 Simulect 62 AVP #D# 62 INCB# [001] 62 SNT MC# 62 EFAPROXYN 62 Octreotide 62 sodium glucose transporter 62 liprotamase 62 Amgen Neulasta R 62 HepaGam B TM 62 Proxinium TM 62 Soliris eculizumab 62 #D#C# 62 MyVax personalized immunotherapy 62 plasmid DNA pDNA 62 Lenocta TM 62 IV APAP 62 triphendiol 62 vaccines oncolytic virus 62 Cardio Vascu Grow 62 Targeted Chemotherapy 62 FluCide 62 hereditary deficiency 62 rhFVIIa 62 inflammatory autoimmune diseases 62 VALSTAR 62 Taclonex R 62 Generx ™ 62 Cinryze ™ 62 HuCNS SC ® 62 Clolar ® 62 AERx ® 62 acid phosphatase PAP 62 candidates Azedra TM 62 Xcellerated T Cells 62 PGL# 62 pegfilgrastim 62 Nexavar sorafenib 62 humanized monoclonal antibodies 62 SMT C# 62 AEG# 62 zanolimumab 62 PLK1 SNALP 62 PI3K/Akt pathway inhibitor 62 Proquin XR 62 Chemophase 62 Pruvel 62 cancer immunotherapies 62 pradefovir 62 5q deletion 62 oral salmon calcitonin 62 tolevamer 62 Icatibant 62 apomorphine hydrochloride 62 elacytarabine 62 Meets Primary Endpoint 62 Pafuramidine 62 bevacizumab Avastin ® 62 ALN TTR# 62 secondary hyperparathyroidism 62 personalized dendritic cell 62 PRTX 62 TNF antagonist 62 Zorbtive TM 62 receptor tyrosine kinase inhibitor 62 immunomodulatory therapy 62 recombinant erythropoietin 62 baminercept 62 Vidaza ® 62 Degarelix 62 MAXY alpha 62 idiopathic pulmonary fibrosis IPF 62 #I TM# 62 edifoligide E2F Decoy 62 elvucitabine 62 herpetic keratitis 62 AERx R 62 gastrointestinal stromal tumors GIST 62 myeloid metaplasia 62 aldehyde dehydrogenase ALDH2 deficiency 62 PentaStaph 62 Preclinical studies suggest 62 Inhalation Solution 62 Pradefovir 62 HGS ETR1 mapatumumab 62 KRN# 62 Hepatitis C virus HCV 62 hyperplasia BPH 62 ATL# [001] 62 fibrotic disease 62 myelofibrosis polycythemia vera 62 histone deacetylase inhibitor 62 TLR9 agonist 62 VALSTAR TM 62 KL4 Surfactant 62 Fabry Disease 62 Telatinib 62 lupus renal disease 62 Nabi HB Intravenous 62 novel antibody therapeutics 62 systemic fungal infections 62 StaphVAX 62 refractory CLL 62 Excellagen 62 beta 1a 62 Mitoxantrone 62 Voraxaze ™ 62 huC# DM4 62 liposomal delivery 62 OncoGel 62 curative therapy 62 dirucotide MBP# 62 Sopherion 62 oral taxane 62 Telintra 62 hypoxia activated prodrug 62 sargramostim 62 compound ISA# 62 treating neuropathic pain 62 PXD# 62 Alequel 62 eprotirome 62 factor VIIa 62 Aclidinium 62 HuMax CD4 62 2 methoxyestradiol 62 endothelin antagonist 62 Morquio 62 refractory Hodgkin 62 Silodosin 62 novel peptide 62 eniluracil 62 HuCAL antibodies 62 AVASTIN 62 Ocrelizumab 62 HuMax EGFr 62 orBec 62 cardio renal 62 Combidex 62 ASONEP 62 valtorcitabine 62 Deferiprone 62 bladder ovarian 62 Aryplase 62 candidate epratuzumab 62 phase IIb trial 62 mecasermin 62 Pertuzumab 62 anticancer compound 62 HDL Mimetic Peptide 62 non nucleoside inhibitor 62 Sphingomab TM 62 TransVax tm 62 cetuximab Erbitux R 62 Cethrin 62 NeoLipid R 62 HspE7 62 Panzem ® 62 therapeutic monoclonal antibodies 62 investigational hepatitis B 62 depsipeptide 62 candidate TNFerade biologic 62 Etubics 62 Genitope Corporation 62 Tocosol Paclitaxel 62 CRD5 62 Anavex #-# 62 StemEx 62 Epratuzumab 62 Survivin antagonist 62 non metastatic osteosarcoma 62 Prosaptide 62 metastatic colorectal 62 DepoDur 62 Phase III Pivotal 62 sorafenib tablets 62 JAK inhibitors 62 LE DT 62 TNF alpha antagonist 62 RNA antagonists 62 recurrent metastatic 62 heparanase 62 CDP# 62 SIR Spheres 62 radiolabeled TM# 62 diabetic gastroparesis 62 TRIOLEX HE# APOPTONE HE# 62 NPC 1C 62 Certolizumab pegol 62 secondary amenorrhea 62 assessing T DM1 62 Allovectin 7 r 62 Plicera 62 leukemia AML 62 Ecallantide 62 ularitide 62 TOCOSOL 62 PROCHYMAL 62 relapsed ALL 62 monoclonal antibody therapies 62 Amigal 62 Uvidem 62 DEEP AF 62 registrational trial 62 Albugon 62 PEGylated Fab fragment 62 sodium stibogluconate 62 ORENCIA R 62 Exherin TM 62 radiotherapeutic 62 Abbokinase 62 gastro intestinal inflammation 62 PSN# [001] 62 Neo Bladder Augment 62 induced macular edema 62 AFREZZA TM 62 OTCBB CVBT 62 autoimmune indications 62 infectious diseases autoimmune diseases 62 basiliximab 62 inhibit metastasis 62 cannabinor 62 alemtuzumab Campath 62 ALN HTT 62 modified glutathione analog 62 Vaccinex 62 immunotherapeutics 62 Human cl 62 ZADAXIN ® 62 CB2 selective receptor agonist 62 novel VDA molecule 62 therapeutic modality 62 palliative radiotherapy 62 Alocrest 62 HIV coinfected 62 recombinant biopharmaceutical 62 Maribavir 62 pediatric Crohn disease 62 EndoTAG TM -1 61 HyperAcute 61 orally dosed 61 Respiratory Syncytial Virus RSV 61 Revimmune 61 OMP #M# 61 acute GvHD 61 anti angiogenic agents 61 Troxatyl TM 61 Hemopurifier ® 61 prescribed proton pump 61 AzaSite Plus 61 Dacogen injection 61 Vascugel 61 TransVax ™ 61 imexon 61 Ribavirin causes 61 midstage trials 61 PSMA ADC 61 midstage clinical 61 Itopride 61 Vandetanib 61 dacetuzumab 61 oral methylnaltrexone 61 deforolimus 61 recurrent glioblastoma multiforme 61 urocortin 2 61 treat dysmenorrhea 61 systemic anaplastic large 61 BIM #A# 61 intravenous methylnaltrexone 61 grade cervical dysplasia 61 cancer neuroendocrine tumor 61 HYVISC R 61 CTAP# 61 Nanobody R 61 Fludara ® 61 ganaxolone 61 erlotinib Tarceva ® 61 recombinant factor VIIa 61 BAY #-# 61 Iluvien ® 61 AERx iDMS 61 Initiates Clinical Trial 61 Mpex 61 MNTX 61 glucokinase activator 61 Roche Herceptin 61 neovascular diseases 61 orally administered inhibitor 61 NS#/#A protease 61 casopitant 61 SAR# [002] 61 Tezampanel 61 immunotherapy treatments 61 DCCR 61 paclitaxel Taxol ® 61 immatics 61 alkylating agent 61 VISICOL R 61 cirrhosis liver failure 61 Scancell 61 OMP #R# 61 Helinx technology 61 NTDDS 61 SIMPONI ® 61 torezolid phosphate 61 ORENCIA ® 61 Allovectin 7 ® 61 lung fibrosis 61 Abrupt discontinuation 61 MEK inhibitors 61 hematologic disorders 61 nalbuphine ER 61 epigenetic therapies 61 novel histone deacetylase 61 psoriasis rheumatoid arthritis 61 PDE# inhibitors 61 fluoropyrimidine 61 human C1 inhibitor 61 novel immunotherapeutic 61 MabThera Rituxan 61 RLY# 61 Solazed ™ 61 PEGPH# 61 intravenous acetaminophen 61 AMEVIVE 61 metastatic neuroendocrine tumors 61 gefitinib Iressa 61 Varespladib 61 DNA methylation biomarkers 61 arterial thrombosis 61 metaglidasen 61 Kinoid 61 VivaGel ™ 61 imatinib Gleevec 61 Wellstat 61 XYOTAX TM 61 aerosolized surfactant 61 candidate Zenvia 61 vapreotide acetate 61 edifoligide 61 DepoCyt 61 PDE4 inhibitor 61 mesylate 61 Enzyme Replacement Therapy 61 Orally administered 61 RezularTM 61 factor TNF receptor 61 Inhaled AAT 61 Vaxfectin TM 61 Hybridon 61 injectable formulations 61 targets Galectin receptors 61 humanized anti 61 Myelodysplastic Syndrome MDS 61 Campath ® 61 pain palliation 61 investigational immunotherapy 61 CR# vcMMAE 61 Stimuvax R 61 Nicole Onetto MD 61 HGS# 61 Glassia 61 inhibitor RG# 61 Velcade bortezomib 61 LibiGel ® 61 Lovaxin C 61 stated Michelle Berrey 61 Lisofylline 61 PEG SN# 61 Veronate 61 RhuDex 61 overactive bladder syndrome 61 CytoFab ™ 61 ALN HPN 61 cysteamine bitartrate 61 non splenectomized 61 Golimumab 61 Steven R. Deitcher 61 topical ocular 61 HCV polymerase inhibitor 61 IGN# 61 interferon alpha 2b 61 Romiplostim 61 MYCAMINE 61 YONDELIS 61 hyperoxaluria 61 Removab 61 DepoBupivacaine TM 61 Genasense ® oblimersen 61 fibrotic disorders 61 phase III isavuconazole 61 Dasatinib 61 antiangiogenic therapy 61 Tovaxin TM 61 PrevOnco ™ 61 DepoVax ™ vaccine 61 levoleucovorin 61 VaxImmune 61 RenaZorb 61 Injectable Suspension 61 OMAPRO 61 cephalosporin antibiotic 61 relapsed acute myelogenous 61 imatinib Gleevec ® 61 accumulate preferentially 61 tumors GIST 61 postoperative ileus POI 61 ThermoDox ® clinical 61 Modrenal 61 Evoltra 61 administered intraperitoneally 61 telomerase therapeutic 61 topically applied SEPA 61 Revlimid lenalidomide 61 Trovax 61 KRAS mutant 61 familial hypercholesterolemia FH 61 TELINTRA R 61 zileuton 61 castrate resistant prostate cancer 61 Elagolix 61 selective S#P# receptor agonist 61 ZEVALIN ® 61 rhThrombin 61 FASLODEX 61 visilizumab 61 Alzhemed TM 61 Completes Patient Enrollment 61 DOS# 61 Src inhibitors 61 Biopump 61 DIFICID ™ 61 lung pancreatic 61 Interferon Beta 61 A1PI 61 ESBA# 61 Nasdaq IDIX biopharmaceutical 61 MOZOBIL 61 Cerashield 61 DDP# 61 biotherapies 61 DepoVax ™ 61 SYN# 61 investigational oral hepatitis C 61 lymphoid malignancies 61 anti CTLA 61 AZILECT ® 61 INTEGRILIN R eptifibatide Injection 61 XL# anticancer compounds 61 Zenyaku Kogyo 61 HERCEPTIN 61 Isolagen Process 61 Liver transplantation 61 optimal dosing regimens 61 Kit CD# positive 61 oropharyngeal candidiasis OPC 61 vivo validation 61 immunomodulatory properties 61 CAPHOSOL 61 Aliskiren 61 Vivaglobin 61 hA# 61 Mipomersen 61 Ozarelix 61 invasive aspergillosis 61 recurrent glioblastoma